TMO
Thermo Fisher Scientific Inc. · Healthcare · Medical - Diagnostics & Research
Input momentum (manajer yang sebanding):
keluasan pemegang -8.7% ·
aliran saham -0.7% ·
posisi baru bersih -9.5%
· formula
Distribusi luas: saham yang turun dan pemegang yang lebih sedikit
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q3 2024
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q3 2026 | 4 | 0 | 875.63K | $561.43M | n/a | −3 |
| Q2 2026 | 189 | +3 | 258.75M | $130.52B | +5 | −3 |
| Q1 2026 | 190 | +2 | 255.88M | $126.62B | +7 | −6 |
| Q4 2025 | 187 | +3 | 274.75M | $159.19B | +4 | n/a |
| Q3 2025 | 29 | -1 | 154.46M | $74.90B | +1 | −3 |
| Q2 2025 | 28 | +3 | 123.95M | $50.25B | +3 | n/a |
| Q1 2025 | 22 | -2 | 60.64M | $30.17B | n/a | −2 |
| Q4 2024 | 24 | +2 | 61.50M | $31.99B | +2 | n/a |
| Q3 2024 | 21 | -2 | 44.46M | $27.48B | n/a | −2 |
| Q2 2024 | 23 | n/a | 44.78M | $24.75B | n/a | n/a |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 10.97M | +10.6% | $6.79B | 0.8% | ▲ Add | 2 | SEC ↗ ×2 |
| 2 | Capital World Investors ✦ | 9.33M | -2.0% | $5.77B | 0.9% | ▼ Trim | 2 | SEC ↗ |
| 3 | Geode Capital Management ✦ (pasif) | 7.66M | +1.7% | $4.72B | 0.4% | ▲ Add | 2 | SEC ↗ ×2 |
| 4 | Norges Bank ✦ (pasif) | 5.59M | +0.4% | $3.46B | 0.5% | ▲ Add | 2 | SEC ↗ |
| 5 | Fisher Asset Management ✦ | 2.64M | +2.5% | $1.63B | 0.7% | ▲ Add | 2 | SEC ↗ |
| 6 | PRIMECAP Management ✦ | 2.57M | -3.5% | $1.59B | 1.2% | ▼ Trim | 2 | SEC ↗ |
| 7 | Wellington Management ✦ | 2.53M | -16.4% | $1.56B | 0.3% | ▼ Trim | 2 | SEC ↗ ×8 |
| 8 | Marshall Wace ✦ | 627.73K | +89576.1% | $388.30M | 0.5% | ▲ Add | 2 | SEC ↗ ×3 |
| 9 | Baillie Gifford ✦ | 603.39K | -2.9% | $373.24M | 0.3% | ▼ Trim | 2 | SEC ↗ ×4 |
| 10 | Two Sigma Investments ✦ | 397.23K | -7.2% | $245.71M | 0.6% | ▼ Trim | 2 | SEC ↗ |
| 11 | Adage Capital Partners ✦ | 357.72K | +1.6% | $221.28M | 0.4% | ▲ Add | 2 | SEC ↗ |
| 12 | D. E. Shaw & Co. ✦ | 337.85K | +67.9% | $208.98M | 0.3% | ▲ Add | 2 | SEC ↗ ×2 |
| 13 | AQR Capital Management ✦ | 211.41K | +115.4% | $129.35M | 0.2% | ▲ Add | 2 | SEC ↗ ×4 |
| 14 | Arrowstreet Capital ✦ | 206.32K | +588.9% | $127.63M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 15 | Citadel Advisors ✦ | 166.19K | -83.1% | $102.80M | 0.1% | ▼ Trim | 2 | SEC ↗ ×2 |
| 16 | Millennium Management ✦ | 122.48K | -78.3% | $75.76M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 17 | Renaissance Technologies ✦ | 48.95K | -79.2% | $30.28M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | Markel Group ✦ | 35.40K | +20.4% | $21.90M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 19 | Dodge & Cox ✦ | 26.77K | -0.1% | $16.56M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 20 | Gotham Asset Management ✦ | 23.41K | +10.0% | $14.48M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 21 | GAMCO Investors ✦ | 4.28K | -0.2% | $2.65M | 0.0% | ▼ Trim | 2 | SEC ↗ |
"Their weight" = porsi posisi dari nilai ekuitas 13F yang dilaporkan manajer tersebut: ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Tidak ada pembeli terlacak baru kuartal ini. |
Telah keluar
| Point72 Asset Management | $186.10M | adalah 0.6% |
| Bridgewater Associates | $18.65M | adalah 0.1% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 1 pemegang, 24.30K saham, $11,944 dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang sekuritas ini yang dilacak: jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Officer · 3.73K lbr · $2.29M
Officer · 400 lbr · $245,752
Officer, Director · 62 lbr · $38,982
Officer, Director · 33 lbr · $20,677
Officer, Director · 101 lbr · $63,166
Officer, Director · 79 lbr · $49,613
Officer, Director · 2.15K lbr · $1.35M
Officer, Director · 1.79K lbr · $1.12M
Officer, Director · 3.01K lbr · $1.89M
Officer, Director · 2.73K lbr · $1.71M
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi